Torrent Pharma Shares Hit Record On Post Result Target Price Hikes

Brokerage firm Citi has raised the stock's target price to Rs 3,000 from Rs 2,960 earlier while maintaining its 'buy' rating.
27-05-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Resignation of Director

In continuation to our earlier letter dated 24-May-24 intimating the desire of Jinesh Shah to step down as the Director of the Company effective from 23-Jul-24, please find the letter attached herewith received from Jinesh Shah as Annexure 1 in this respect
24-05-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032024.mp3
24-05-2024

Torrent Pharmaceuticals Results Earnings Call for Q4FY24

Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
24-05-2024

Torrent Pharma Plans To Raise Rs 5,000 Crore Through QIP

The drugmaker's net profit rose 56.4% year-on-year to Rs 449 crore in the quarter-ended March.
24-05-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Record Date Intimation

Record date intimation for Final Dividend for the year 2023-24
24-05-2024
Next Page
Close

Let's Open Free Demat Account